BamSEC and AlphaSense Join Forces
Learn More

Poseida Therapeutics Inc.

NASDAQ: PSTX    
Share price (12/20/24): $9.45    
Market cap (12/20/24): $921 million

Indentures Filter

EX-4.14
from S-3 18 pages Poseida Therapeutics, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of Poseida Therapeutics, Inc. Form of Debt Securities Warrant Agreement
12/34/56
EX-4.13
from S-3 20 pages Poseida Therapeutics, Inc. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as of Poseida Therapeutics, Inc. Form of Preferred Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.12
from S-3 20 pages Poseida Therapeutics, Inc. and , as Warrant Agent Form of Common Stock Warrant Agreement Dated as of Poseida Therapeutics, Inc. Form of Common Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.9
from S-3 55 pages Poseida Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [•], 20__ Debt Securities
12/34/56
EX-4.12
from S-3 19 pages Poseida Therapeutics, Inc. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as of Poseida Therapeutics, Inc. Form of Preferred Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.11
from S-3 17 pages Poseida Therapeutics, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of Poseida Therapeutics, Inc. Form of Debt Securities Warrant Agreement
12/34/56
EX-4.10
from S-3 19 pages Poseida Therapeutics, Inc. and , as Warrant Agent Form of Common Stock Warrant Agreement Dated as of Poseida Therapeutics, Inc. Form of Common Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.7
from S-3 47 pages Poseida Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [●], 202 Debt Securities
12/34/56
EX-4.6
from 10-K 4 pages Description of Common Stock
12/34/56
EX-4.2
from S-1/A 53 pages Poseida Therapeutics, Inc. Amended and Restated Investors’ Rights Agreement
12/34/56
EX-4.5
from S-1 12 pages Warrant [ ] to Purchase Stock
12/34/56
EX-4.4
from S-1 12 pages Warrant to Purchase Stock
12/34/56
EX-4.3
from S-1 12 pages Warrant [__] to Purchase Stock
12/34/56
EX-4.1
from S-1 2 pages The Company Will Furnish Without Charge to Each Stockholder Who So Requests, a Summary of the Powers, Designations, Preferences and Relative, Participating, Optional or Other Special Rights of Each Class of Stock of the Company and the Qualifications, Limitations or Restrictions of Such Preferences and Rights, and the Variations in Rights, Preferences and Limitations Determined for Each Series, Which Are Fixed by the Certificate of Incorporation of the Company, as Amended, and the Resolutions of the Board of Directors of the Company, and the Authority of the Board of Directors to Determine Variations for Future Series. Such Request May Be Made to the Office of the Secretary of the Company or to the Transfer Agent. the Board of Directors May Require the Owner of a Lost or Destroyed Stock Certificate, or His Legal Representatives, to Give the Company a Bond to Indemnify It and Its Transfer Agents and Registrars Against Any Claim That May Be Made Against Them on Account of the Alleged Loss or Destruction of Any Such Certificate
12/34/56
EX-4.5
from DRS 12 pages Warrant [ ] to Purchase Stock
12/34/56
EX-4.4
from DRS 12 pages Warrant to Purchase Stock
12/34/56
EX-4.3
from DRS 12 pages Warrant [__] to Purchase Stock
12/34/56
EX-4.2
from DRS 39 pages Poseida Therapeutics, Inc. Amended and Restated Investors’ Rights Agreement
12/34/56
EX-4.5
from S-1/A 12 pages Warrant [ ] to Purchase Stock
12/34/56
EX-4.1
from S-1/A 2 pages Indenture or similar
12/34/56